Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 2/2005

01-03-2005

Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer

Authors: Yen-Ching Chen, Huey-Jen Jenny Su, Yu-Liang Leon Guo, E. Andres Houseman, David C. Christiani

Published in: Cancer Causes & Control | Issue 2/2005

Login to get access
Metadata
Title
Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer
Authors
Yen-Ching Chen
Huey-Jen Jenny Su
Yu-Liang Leon Guo
E. Andres Houseman
David C. Christiani
Publication date
01-03-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 2/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-004-2235-1

Other articles of this Issue 2/2005

Cancer Causes & Control 2/2005 Go to the issue

OriginalPaper

Cancer-specific beliefs and survival: A population-based study of African-American and White breast cancer patients

OriginalPaper

Book reveiw Review of Molecular Biology of Human Cancers (An Advanced Student’s Text, by Wolfgang Schulz, Department of Urology and Center for Biological and Medical Research, Heinrich Heine University, Düsseldorf) ISBN 1-4020-3185-8

OriginalPaper

A national framework for cancer surveillance in the United States

OriginalPaper

The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)

OriginalPaper

What do cancer survivors believe causes cancer? (United States)

OriginalPaper

Brief Report: Towards a dietary prevention of hereditary breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits